文献库，生知库 | 链接生命科学的每一步

日期影响因子

Non-thyroidal illness syndrome predicts poor prognosis in hepatocellular carcinoma patients treated with atezolizumab and bevacizumab

非甲状腺疾病综合征预示着接受阿特珠单抗和贝伐珠单抗治疗的肝细胞癌患者预后不良

期刊:Cancer Immunology Immunotherapy

影响因子:5.1

doi:10.1007/s00262-026-04308-z

Chen, I-Wen; Lin, Cheng-Wei; Lin, Po-Ting; Teng, Wei; Su, Chung-Wei; Wu, Tsung-Han; Hsieh, Yi-Chung; Chen, Wei-Ting; Lin, Chen-Chun; Lin, Shi-Ming; Lin, Chun-Yen

细胞生物学

免疫/内分泌

发表日期：2026

文献求助收藏

Proton Radiotherapy Alone versus Combined with Immunotherapies or Tyrosine Kinase Inhibitors for Barcelona Clinic Liver Cancer Stage B or C Hepatocellular Carcinoma

质子放射疗法单独使用与联合免疫疗法或酪氨酸激酶抑制剂治疗巴塞罗那临床肝癌B期或C期肝细胞癌的疗效比较

期刊:Liver Cancer

影响因子:9.1

doi:10.1159/000550067

Hsieh, Rodney Cheng-En; Chen, Willy Po-Yuan; Lee, Jin-Chiao; Lin, Chia-Hsin; Chang, Yu-Chen; Lee, Chao-Wei; Chan, Kun-Ming; Hung, Hao-Chien; Kuo, Tony; Lin, Shen-Yen; Chen, Tse-Ching; Wu, Ting-Jung; Su, Chung-Wei; Chou, Hong-Shiue; Cheng, Chih-Hsien; Hsieh, Yi-Chung; Huang, Chen-Yang; Tran, Khac Chien; Welsh, James; Hsieh, Jason Chia-Hsun

细胞生物学

免疫/内分泌

发表日期：2025

文献求助收藏

Moderate Immune-Related Liver Injury Is a Good Factor in Patients with Hepatoma Under Atezolizumab Plus Bevacizumab

中度免疫相关性肝损伤是接受阿特珠单抗联合贝伐珠单抗治疗的肝癌患者的良好预后因素

影响因子:4.4

doi:10.3390/cancers17193157

Wu, Tai-Chi; Lin, Po-Ting; Teng, Wei; Shen, Eric Yi-Liang; Su, Chung-Wei; Hsieh, Yi-Chung; Chen, Wei-Ting; Wu, Tsung-Han; Lin, Chen-Chun; Lin, Shi-Ming; Lin, Chun-Yen

免疫/内分泌

发表日期：2025

文献求助收藏

Combination of Hepatic Arterial Infusion Chemotherapy with Tyrosine Kinase Inhibitor Provides Better Survival in Advanced Hepatocellular Carcinoma Patients

肝动脉灌注化疗联合酪氨酸激酶抑制剂可提高晚期肝细胞癌患者的生存率

期刊:Journal of Hepatocellular Carcinoma

影响因子:3.4

doi:10.2147/JHC.S502922

Liu, Chung-Wei; Lin, Po-Ting; Teng, Wei; Chen, Wei-Ting; Su, Chung-Wei; Hsieh, Yi-Chung; Lin, Chen-Chun; Lin, Chun-Yen; Lin, Shi-Ming

细胞生物学

发表日期：2025

文献求助收藏

TKI plus ICI versus ICI alone in high tumor burden hepatocellular carcinoma: a retrospective cohort study

高肿瘤负荷肝细胞癌中TKI联合ICI与单用ICI的疗效比较：一项回顾性队列研究

期刊:Journal of Cancer Research and Clinical Oncology

影响因子:2.8

doi:10.1007/s00432-025-06381-w

Lin, Po-Ting; Teng, Wei; Chen, Wei-Ting; Su, Chung-Wei; Hsieh, Yi-Chung; Lin, Chen-Chun; Lin, Chun-Yen; Lin, Shi-Ming

细胞生物学

发表日期：2025

文献求助收藏

Association of aspirin use alone with mortality and liver-related events in MASLD: a multi-institutional three-year study

阿司匹林单药治疗与MASLD患者死亡率和肝脏相关事件的关联：一项多中心三年研究

doi:10.1080/07853890.2025.2573146

Huang, Chien-Hao; Wang, Chun-Li; Wu, Victor Chien-Chia; Hsieh, Yi-Chung; Wu, Chia-Ling; Zeng, Z-Fan; Huang, Yu-Tung; Hsu, Chao-Wei; Chien, Rong-Nan; Chang, Shang-Hung

发表日期：2025

文献求助收藏

Rapid lightsheet fluorescence imaging of whole Drosophila brains at nanoscale resolution by potassium acrylate-based expansion microscopy

利用基于丙烯酸钾的膨胀显微镜对整个果蝇大脑进行纳米级分辨率的快速光片荧光成像

期刊:Nature Communications

影响因子:14.7

doi:10.1038/s41467-024-55305-8

Xuejiao Tian #, Tzu-Yang Lin #, Po-Ting Lin, Min-Ju Tsai, Hsin Chen, Wen-Jie Chen, Chia-Ming Lee, Chiao-Hui Tu, Jui-Cheng Hsu, Tung-Han Hsieh, Yi-Chung Tung, Chien-Kai Wang, Suewei Lin, Li-An Chu, Fan-Gang Tseng, Yi-Ping Hsueh, Chi-Hon Lee, Peilin Chen, Bi-Chang Chen0

发表日期：2024

文献求助收藏

Do low skeletal muscle bulk and disturbed body fat mass impact tumor recurrence in stage I/II hepatocellular carcinoma undergoing surgery? An observational cohort study

骨骼肌量低和体脂分布紊乱是否会影响接受手术治疗的I/II期肝细胞癌患者的肿瘤复发？一项观察性队列研究

期刊:International Journal of Surgery

影响因子:10.1

doi:10.1097/JS9.0000000000001905

Lee, Chao-Wei; Tsai, Hsin-I; Hsu, Hsiao-Mei; Yu, Ming-Chin; Lee, Wei-Chen; Wang, Chih-Chi; Hsieh, Yi-Chung; Lin, Cheng-Yu; Cheng, Mei-Ling; Lo, Chi-Jen; Wang, Ching-Ting; Lin, Yu-Ching

细胞生物学

发表日期：2024

文献求助收藏

Polygenic Risk Score Predicts Earlier-Onset Adult Systemic Lupus Erythematosus and First-Year Renal Diseases in a Taiwanese Cohort

多基因风险评分可预测台湾人群中成人系统性红斑狼疮的早期发病和第一年肾脏疾病

期刊:RMD Open

影响因子:4.7

doi:10.1136/rmdopen-2023-003293

Chen, Yen-Ju; Hsiao, Tzu-Hung; Lin, Ying-Cheng; Jeng, Wen-Juei; Mao, Chien-Lin; Wei, Chia-Yi; Hsieh, Yi-Chung; Huang, Chih-Jen; Pan, Mei-Hung; Chen, I-Chieh; Lin, Ching-Heng; Chen, Yi-Ming; Yang, Hwai-I

免疫/内分泌

发表日期：2024

文献求助收藏

Comparing Lenvatinib/Pembrolizumab with Atezolizumab/Bevacizumab in Unresectable Hepatocellular Carcinoma: A Real-World Experience with Propensity Score Matching Analysis

比较乐伐替尼/帕博利珠单抗与阿特珠单抗/贝伐珠单抗治疗不可切除肝细胞癌的疗效：基于倾向评分匹配分析的真实世界经验

影响因子:4.4

doi:10.3390/cancers16203458

Hsu, Yu-Chun; Lin, Po-Ting; Teng, Wei; Hsieh, Yi-Chung; Chen, Wei-Ting; Su, Chung-Wei; Wang, Ching-Ting; Chai, Pei-Mei; Lin, Chen-Chun; Lin, Chun-Yen; Lin, Shi-Ming

细胞生物学

发表日期：2024

文献求助收藏